Clonal Evolution of the HER2 L755S Mutation Leads to Acquired HER-targeted Therapy Resistance That Can Be Reversed by the Irreversible HER1/2 Inhibitor Afatinib
2016
Keywords:
- Correction
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI